Health Condition 1: K758- Other specified inflammatory liverdiseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with case of NAFLD grade- I/II/III by USG.
Exclusion criteria
Exclusion criteria: 1) Patients who are contraindicated for virechana karma- like lower GI bleeding, Prolapse of rectum, incontinence of stool, pregnant and lactating mothers etc. will not be included in the trial group. 2) Patients taking antifungal, antibacterial, or antibiotic medication. 3) Patients with Ascites, Liver cirrhosis, Oesophageal varices, Jaundice, Cholelithiasis. 4) Patients with history of Cholecystectomy. 5) Patients requiring emergency treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the changes in Fibroscan and USG post Virechana karma in the patients of NAFLD.Timepoint: After 1 month i.e 31st day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the effectiveness of Virechana karma in improving the subjective parameters in patients of NAFLD.Timepoint: After 1 month i.e 31st day;2. To assess the efficacy of Virechana Karma and standard treatment protocol on the biomarkers of liver steatosis (Fibroscan, USG, LFT, Lipid profile) in the subjects of NAFLD.Timepoint: After 1 month i.e 31st day | — |
Countries
India
Contacts
Ayurvedic and Unani Tibbia college and hospital